180 related articles for article (PubMed ID: 7578396)
1. Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity.
Fakhrai H; Shawler DL; Gjerset R; Naviaux RK; Koziol J; Royston I; Sobol RE
Hum Gene Ther; 1995 May; 6(5):591-601. PubMed ID: 7578396
[TBL] [Abstract][Full Text] [Related]
2. Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts.
Tsai SC; Gansbacher B; Tait L; Miller FR; Heppner GH
J Natl Cancer Inst; 1993 Apr; 85(7):546-53. PubMed ID: 8455201
[TBL] [Abstract][Full Text] [Related]
3. Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector.
Kim JH; Gong SJ; Yoo NC; Lee H; Shin DH; Uhm HD; Jeong SJ; Cho JY; Rha SY; Kim YS; Chung HC; Roh JK; Min JS; Kim BS
Oncol Rep; 1999; 6(1):49-54. PubMed ID: 9864400
[TBL] [Abstract][Full Text] [Related]
4. Local IL-4 delivery enhances immune reactivity to murine tumors: gene therapy in combination with IL-2.
Pippin BA; Rosenstein M; Jacob WF; Chiang Y; Lotze MT
Cancer Gene Ther; 1994 Mar; 1(1):35-42. PubMed ID: 7621236
[TBL] [Abstract][Full Text] [Related]
5. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.
Chiyo M; Shimozato O; Yu L; Kawamura K; Iizasa T; Fujisawa T; Tagawa M
Int J Cancer; 2005 Jun; 115(3):437-42. PubMed ID: 15688376
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT-26 model of colorectal carcinoma.
Shawler DL; Dorigo O; Gjerset RA; Royston I; Sobol RE; Fakhrai H
J Immunother Emphasis Tumor Immunol; 1995 May; 17(4):201-8. PubMed ID: 7582256
[TBL] [Abstract][Full Text] [Related]
7. Retroviral-mediated IL-2 gene transfer into murine neuroblastoma.
Cho HS; Song JY; Park CY; Lyu CJ; Kim BS; Kim KY
Yonsei Med J; 2000 Feb; 41(1):76-81. PubMed ID: 10731923
[TBL] [Abstract][Full Text] [Related]
8. Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness.
Govaerts AS; Guillaume T; André M; Bayat B; Feyens AM; Hawley TS; Fong AZ; Hawley RG; Symann M
Cancer Gene Ther; 1999; 6(5):447-55. PubMed ID: 10505855
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.
Eguchi J; Hiroishi K; Ishii S; Baba T; Matsumura T; Hiraide A; Okada H; Imawari M
Gene Ther; 2005 May; 12(9):733-41. PubMed ID: 15772692
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study.
Sobol RE; Shawler DL; Carson C; Van Beveren C; Mercola D; Fakhrai H; Garrett MA; Barone R; Goldfarb P; Bartholomew RM; Brostoff S; Carlo DJ; Royston I; Gold DP
Clin Cancer Res; 1999 Sep; 5(9):2359-65. PubMed ID: 10499605
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiency.
Cayeux S; Richter G; Becker C; Beck C; Aicher A; Pezzutto A; Dörken B; Blankenstein T
Eur J Immunol; 1997 Jul; 27(7):1657-62. PubMed ID: 9247574
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of retroviral vectors for interleukin-2 gene therapy.
Fakhrai H; Shawler DL; Van Beveren C; Lin H; Dorigo O; Solomon MJ; Gjerset RA; Smith L; Bartholomew RM; Boggiano CA; Gold DP; Sobol RE
J Immunother; 1997 Nov; 20(6):437-48. PubMed ID: 9409449
[TBL] [Abstract][Full Text] [Related]
13. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
[TBL] [Abstract][Full Text] [Related]
14. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts.
Ugai S; Shimozato O; Kawamura K; Wang YQ; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
Cancer Gene Ther; 2003 Mar; 10(3):187-92. PubMed ID: 12637939
[TBL] [Abstract][Full Text] [Related]
15. Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
Tanaka M; Saijo Y; Sato G; Suzuki T; Tazawa R; Satoh K; Nukiwa T
Cancer Gene Ther; 2000 Nov; 7(11):1481-90. PubMed ID: 11129290
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study.
Kang WK; Park C; Yoon HL; Kim WS; Yoon SS; Lee MH; Park K; Kim K; Jeong HS; Kim JA; Nam SJ; Yang JH; Son YI; Baek CH; Han J; Ree HJ; Lee ES; Kim SH; Kim DW; Ahn YC; Huh SJ; Choe YH; Lee JH; Park MH; Kong GS; Park EY; Kang YK; Bang YJ; Paik NS; Lee SN; Kim SH; Kim S; Robbins PD; Tahara H; Lotze MT; Park CH
Hum Gene Ther; 2001 Apr; 12(6):671-84. PubMed ID: 11426466
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of peritoneal dissemination of murine colon carcinoma cells by administrating retrovirus harboring IL-2 gene.
Gunji Y; Tasaki K; Tagawa M; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Sakiyama S
Cancer Gene Ther; 1998; 5(6):339-43. PubMed ID: 9917087
[TBL] [Abstract][Full Text] [Related]
18. Human lung tumor cell secretion of interleukin-2 for protection against tumor engraftment.
Alosco T; Gansbacher B; Bankert R; Takita H; Petrelli N
Ann Surg Oncol; 1994 May; 1(3):229-35. PubMed ID: 7842293
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
20. Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors.
Lichtor T; Glick RP; Tarlock K; Moffett S; Mouw E; Cohen EP
Cancer Gene Ther; 2002 May; 9(5):464-9. PubMed ID: 11961669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]